|
|
| Mesothelioma Asbestos Class Action |
RSS Feed URL : http://www.asbestos-class-action.info/wp-rss2.php
Category : Health
Total Views : 9 |
| Latest entries from this feed url |
Alimta treatment for malignant pleural mesothelioma
The company's Alimta treatment for malignant pleural mesothelioma saw sales of $73.1 million, up from $40 million in the third quarter, while sales of depression treatment Cymbalta were $61.3 million, compared with $32.5 million in the third quarter, mainly due to initial wholesaler stocking. Fourth-quarter sales of Forteo, a treatment ...
Malignant Pleural Mesothelioma European Prognosis Score Validated
European Prognosis Score Validated in Malignant Pleural Mesothelioma: A recent article in the Journal of Clinical Oncology reports that the current model for determining the prognosis for malignant pleural mesothelioma (MPM) is a valid tool for determining high and low-risk patients for clinical trial participation.
The current model for determining the ...
Asbestos Indictment Rallies Montanans
They're getting ready for the Asbestos Health Fair in this old mining town. Posters promise "Door Prizes!!" and "Blood draw to participate in ongoing research!" Companies that sell home oxygen supplies will send reps. Doctors and researchers will be here. There will be consultants to help asbestosis victims apply for ...
Deaths from mesothelioma will peak within ten years…
Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer. Mesothelioma is a type of cancer in the lining of the lungs or the lining ...
asbestos reform and asbestos related litigation is on fire…
On the subject of blog business models, Michael Buffington explains how he launched Asbestos News, a niche content blog designed to generate money via Google AdWords based on content supplied by Google Alerts:
The subject matter, while weighty and all that, is of little importance to ...
Companies Look to Plug the Asbestos Drain
Proponents of a bill to rein in asbestos lawsuits say this could be the year legislation is finally approved on Capitol Hill. Court cases have cost companies billions of dollars, while also helping to push dozens of firms into bankruptcy. But given the mounting debate over the proposed legislation, ...
President Bush: “frivolous asbestos claims.”
Sometimes the ironic timing of events in our public life is so striking as to cause one to wonder whether the Great Scriptwriter in the Sky is trying to make a point. Thus, the word that the Senate voted for tort deform last week came just a few days after ...
Allos Therapeutics, Inc. (ALTH) Initiates Phase 1 PDX Study
Allos Therapeutics, Inc. today announced the initiation of a Phase 1 dose escalation study of its investigational drug PDX (pralatrexate) with vitamin B12 and folic acid supplementation in patients with previously-treated (Stage IIIB-IV) advanced non-small cell lung cancer (NSCLC). This open-label, non-randomized study will seek to enroll one to six ...
Bush makes litigation reform stop in Macomb.
President George W. Bush made his first stop in Michigan since his re-election, and the main topic of his agenda was asbestos litigation reform. Bush spoke to an invitation-only crowd at the Macomb Center for the Performing Arts Jan. 7. He was joined by four other guests, one being an ...
Crane Q4 profit rises on gains, abandons asbestos deal
SAN FRANCISCO (CBS.MW) -- Crane Co., an industrial products maker, late Monday reported a higher fourth-quarter profit, helped by a one-time gain resulting from the termination of its planned asbestos settlement.
Crane Q4 profit rises on gains, abandons asbestos deal
The Stamford, Conn.-based company posted ...
|
|
|
